They prevent the immune system from attacking the body's own cells and curb harmful inflammation in our bodies. In lupus, ...

The Lupus Research Alliance (LRA) is proud to announce the inaugural recipients of the new Targeted Research Program on ...

Although chimeric antigen receptor T-cell therapy has raised hopes for long-term remission in autoimmune disease, it has ...

The FDA has agreed to review an application from Roche that seeks approval in the U.S. of obinutuzumab as a treatment for ...

Now, researchers from Yale have found that a specific bacterium, called Enterococcus gallinarum, can move from the gut to ...

Having established success in cancer, biopharma is now looking to leverage CAR T therapies against a new target, autoimmune ...

Air pollution significantly contributes to autoimmune diseases such as rheumatoid arthritis, multiple sclerosis, lupus, type ...

Uniklinikum Erlangen at Friedrich-Alexander-Universität Erlangen-Nürnberg has successfully treated more than 45 people with autoimmune diseases using ...

Inflammation caused by lupus can affect many different body systems including your joints, skin, kidneys, blood cells, brain, heart and lungs. Lupus can be difficult to diagnose because its signs ...

The Food and Drug Administration (FDA) has accepted the supplemental Biologics License Application (sBLA) for obinutuzumab (Gazyva ®) for the treatment of lupus nephritis. Obinutuzumab is a monoclonal ...

Dr. Kean has engineered Tregs with CARs that recognize OX40L, a molecule on the surface of immune cells in people with active lupus. She will now test these “OX40L-CAR-Tregs" in human cells and ...